{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:30:58Z","timestamp":1778873458695,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.virol.2006.09.029","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T07:21:59Z","timestamp":1165994519000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse\u00ae"],"prefix":"10.1016","volume":"361","author":[{"given":"Melissa","family":"Coughlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gin","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie K.","family":"Masterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica A.","family":"Moksa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Farzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Babcook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bellur S.","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2006.09.029_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.inf.0000145815.70485.f7","article-title":"Coronaviruses from common colds to severe acute respiratory syndrome","volume":"23","author":"Baker","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virol.2006.09.029_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jviromet.2004.04.009","article-title":"Development and characterization of neutralizing monoclonal antibody to the SARS-coronavirus","volume":"120","author":"Berry","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2006.09.029_bib3","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2006.09.029_bib4","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2006.09.029_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/CS20050188","article-title":"SARS: clinical presentation, transmission, pathogenesis and treatment options","volume":"110","author":"Chan","year":"2006","journal-title":"Clin. Sci."},{"key":"10.1016\/j.virol.2006.09.029_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Chen","year":"2005","journal-title":"Eur. J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2006.09.029_bib7","first-page":"191","article-title":"Production of human antibodies from transgenic mice","volume":"248","author":"Davis","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2006.09.029_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/1521-4141(200002)30:2<534::AID-IMMU534>3.0.CO;2-P","article-title":"The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans","volume":"30","author":"Gallo","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2006.09.029_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/427242","article-title":"Development and characterization of a Severe Acute Respiratory Syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice","volume":"191","author":"Greenough","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2006.09.029_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2006.09.029_bib11","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2006.09.029_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"He","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.09.029_bib13","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1128\/JVI.78.12.6134-6142.2004","article-title":"S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients","volume":"78","author":"Hofmann","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.09.029_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0002-9440(10)64164-8","article-title":"Fully humanized neutralizing Abs to interleukin-8 (ABX-IL8) inhibits angiogenesis, tumor growth, and metastasis of human melanoma","volume":"161","author":"Huang","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virol.2006.09.029_bib15","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1073\/pnas.0402753101","article-title":"Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus","volume":"101","author":"Ingallinella","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2006.09.029_bib16","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2006.09.029_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2006.09.029_bib18","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.virol.2006.09.029_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are the natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.virol.2006.09.029_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2249.2005.02864.x","article-title":"Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity","volume":"141","author":"Lin","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.virol.2006.09.029_bib21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt1135","article-title":"Human antibodies from transgenic animals","volume":"23","author":"Lonberg","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2006.09.029_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/eji.1830210419","article-title":"Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes","volume":"21","author":"Marks","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2006.09.029_bib23","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2006.09.029_bib24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbrc.2005.07.002","article-title":"Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8","volume":"334","author":"Rathanaswami","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2006.09.029_bib25","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2006.09.029_bib26","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2006.09.029_bib27","first-page":"536","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2006.09.029_bib28","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.09.029_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nbt0391-266","article-title":"Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo","volume":"9","author":"Tempest","year":"1991","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2006.09.029_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/hyb.1994.13.183","article-title":"A humanized anti-tumor necrosis factor-alpha monoclonal antibody that acts as a partial, competitive antagonist of the template antibody","volume":"13","author":"Tempest","year":"1994","journal-title":"Hybridoma"},{"key":"10.1016\/j.virol.2006.09.029_bib31","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1126\/science.1092002","article-title":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China","volume":"303","author":"The Chinese SARS Molecular Epidemiology Consortium","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.virol.2006.09.029_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2006.09.029_bib33","doi-asserted-by":"crossref","first-page":"20836","DOI":"10.1074\/jbc.M400759200","article-title":"Structural characterization of the SARS-Coronavirus spike S fusion protein core","volume":"279","author":"Tripet","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2006.09.029_bib34","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2006.09.029_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbrc.2004.07.084","article-title":"Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain","volume":"322","author":"Xiao","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2006.09.029_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2006.09.029_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2006.09.029_bib38","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/JVI.78.13.6938-6945.2004","article-title":"Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.09.029_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20499","article-title":"Antibody response against SARS coronavirus are correlated with disease outcome of infected individuals","volume":"78","author":"Zhang","year":"2006","journal-title":"J. Med. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206006854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206006854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:47:40Z","timestamp":1758584860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682206006854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0042682206006854"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2006.09.029","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse\u00ae","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2006.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}